India’s Ministry of Health agreed to grant access to bedaquiline to an 18-year old girl suffering from extremely drug-resistant tuberculosis (XDR-TB). The girl, who was diagnosed with XDR-TB in 2013, was previously unable to receive treatment with bedaquiline due to stringent restrictions on the new drug’s use in India. The girl’s father brought her predicament to court, asking that the Delhi High Court direct the government to administer the drug immediately to his daughter. On January 18th, 2017, following a month-long deliberation process that has been closely followed by public health experts across the globe, the High Court decided to grant the girl access to bedaquiline.
Read more about the lawsuit and hearing here.